Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Valeritas Holdings Inc (VLRX)

Valeritas Holdings Inc (VLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees

Valeritas Holdings, Inc. (NASDAQ: VLRX) ("Valeritas" or the "Company"), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, today announced an agreement to sell substantially...

VLRX : 0.26 (-9.32%)
ZEAL : 37.93 (-3.26%)
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, today announced revised...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas' V-Go(R) Wearable Insulin Delivery Device Demonstrates Reductions in A1c and Daily Insulin Usage

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, today announced additional data from the VERDICT study presented at the 19 Annual...

VLRX : 0.26 (-9.32%)
Valeritas Announces Third Quarter 2019 Financial Results

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes,...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at the World Congress of Neurology (WCN 2019)

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas to Report Third Quarter 2019 Financial Results on November 12, 2019

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go(R) Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, today announced that...

VLRX : 0.26 (-9.32%)
GLP-1 Analogue Delivered Robustly via Subcutaneous Infusion with Valeritas Proprietary h-Patch(TM) Wearable Device in Preclinical Study

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses their proprietary h-Patch(TM) technology, announced today positive...

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) Apomorphine Study Data at Global Experts Meeting on Frontiers in Alzheimer's Disease & Dementia

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Cannabidiol (CBD) Study at the American Epilepsy Society's Annual Meeting

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today a poster...

VLRX : 0.26 (-9.32%)
Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Apomorphine Study at the World Congress of Neurology (WCN 2019)

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today a poster...

VLRX : 0.26 (-9.32%)
Valeritas Hosts Educational Symposium and Participates in the Metabolic & Endocrine Disease Summit (MEDS) East

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today it will...

VLRX : 0.26 (-9.32%)
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock

- Debt Exchange Expected to Save Approximately $8 Million in Cash Interest Expense -

VLRX : 0.26 (-9.32%)
Medtronic's All Business Lines Grow Despite Cost Concerns

Within Diabetes group, Medtronic (MDT) is seeing a strong adoption of the Guardian Connect Smart CGM system.

MDT : 108.53 (-2.53%)
GWPH : 117.05 (-3.04%)
VLRX : 0.26 (-9.32%)
NTRP : 1.19 (unch)
Boston Scientific (BSX) Upbeat on Results of EVOLVE Study

Boston Scientific (BSX) is hopeful about robust data outcome on DAPT study as the therapy duration might prove to be a superior treatment option.

GWPH : 117.05 (-3.04%)
BSX : 39.91 (-2.85%)
NTRP : 1.19 (unch)
VLRX : 0.26 (-9.32%)
Haemonetics Grows on Strong Plasma, Hemostasis Management

Haemonetics (HAE) is gaining traction from a steady progress in Plasma franchise.

HAE : 110.14 (-4.07%)
BAX : 86.99 (-2.84%)
AMED : 185.24 (-3.36%)
VLRX : 0.26 (-9.32%)
NuVasive Announces Innovations in Robotics Spine Surgery Line

NuVasive (NUVA) aims to speed up the adoption of less invasive spine surgery through robotics.

GWPH : 117.05 (-3.04%)
NUVA : 70.91 (-3.23%)
NTRP : 1.19 (unch)
VLRX : 0.26 (-9.32%)
Valeritas Announces Participation on "The Cutting Edge of Cannabinoid Science" Panel at the CBD Expo EAST Conference

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today that Dr....

VLRX : 0.26 (-9.32%)
Valeritas Presents Positive h-Patch(TM) CBD Study Data at CannMed Conference

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced positive data...

VLRX : 0.26 (-9.32%)
Valeritas Announces Presentation of Preclinical h-Patch(TM) CBD Study at CannMed Conference

Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go Wearable Insulin Delivery device, which uses its proprietary h-Patch(TM) technology, announced today data from...

VLRX : 0.26 (-9.32%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -1.74 , SEDG -2.63 , THC -3.44 , TER -2.25 , LITE -2.20
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar